News

Net profit of Hester Biosciences rose 489.90% to Rs 96.98 crore in the quarter ended June 2026 as against Rs 16.44 crore during the previous quarter ended June 2025. Sales declined 8.17% to Rs 77.24 crore in the quarter ended June 2026 as against Rs 84.11 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales77.2484.11 -8 OPM %29.4927.12 - PBDT23.3824.37 -4 PBT16.3320.19 -19 NP96.9816.44 490 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 30 July 2026.

Hester Biosciences announced that the 39th Annual General Meeting(AGM) of the company will be held on 21 July 2026.

Hester Biosciences announced that the Board of Directors of the Company at its meeting held on 15 May 2026, inter alia, have recommended the final dividend of Rs 11 per equity Share (i.e. 110%) , subject to the approval of the shareholders.

Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025. Sales rose 22.19% to Rs 100.11 crore in the quarter ended March 2026 as against Rs 81.93 crore during the previous quarter ended March 2025.For the full year,net profit rose 102.40% to Rs 55.64 crore in the year ended March 2026 as against Rs 27.49 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 332.60 crore in the year ended March 2026 as against Rs 311.10 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales100.1181.93 22 332.60311.10 7 OPM %34.2923.41 -26.0619.63 - PBDT28.067.92 254 91.7856.37 63 PBT22.153.75 491 72.9039.57 84 NP15.981.29 1139 55.6427.49 102 Powered by Capital Market - Live News